Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celcuity logo — company profile

Celcuity

Founded 2012 United States Minneapolis, United States 83 employees Post-IPO Debt Total: $335.67M Biotechnology, Health Care +1

General Information

Company Name Celcuity
Founded Year 2012
Location United States Minneapolis, United States
Employees 83
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Celcuity. To contact Celcuity, visit celcuity.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Celcuity

Celcuity is a clinical-stage biotechnology company with a mission to extend the lives of cancer patients through an integrated therapeutic and companion diagnostic strategy. The company's lead therapeutic candidate is gedatolisib, a potent, reversible dual inhibitor targeting all Class I isoforms of PI3K and mTOR. Celcuity aims to initiate a Phase 3 study for gedatolisib in patients with HR+/HER2- advanced breast cancer in 2022. Additionally, their CELsignia companion diagnostic platform can analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from approved targeted therapies. Founded in 2012 and headquartered in Minneapolis, Celcuity received a $50.00MPost-IPO Equity investment on 18 October 2023. For further information about Celcuity, visit www.celcuity.com.

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $62.00M 1
Innovatus Capital Partners
Innovatus Capital Partners
30 May 2024
Post IPO Equity $60.00M 6
Vivo Capital BVF Partners Driehaus Capital Management
Vivo Capital, BVF Partners +4
30 May 2024
Post IPO Equity $50.00M -
18 Oct 2023
Post IPO Debt $20.00M -
12 Dec 2022
Post IPO Equity $100.00M 6
New Enterprise Associates RA Capital Management Commodore Capital
New Enterprise Associates, RA Capital Management +4
16 May 2022
Post IPO Equity $24.00M -
24 Feb 2021
Post IPO Debt $3.75K -
19 Oct 2019
Post IPO Equity $5.81K -
04 Nov 2018
Convertible Note $2.59M -
19 May 2017
Convertible Note $5.75M -
02 May 2017

View All 13 Funding Rounds

Celcuity Alternatives & Competitors

View All Alternatives
Celcuity vs
ENB Therapeutics
ENB Therapeutics United States

Overcoming Immunotherapy resistance

Series A
6 employees
Biotechnology, Health and Wellness
Celcuity vs
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. United States

Delivering a cancer-free future

Post-IPO Equity
11 employees
Biotechnology, Health Care
Celcuity vs
AbilityPharma
AbilityPharma Spain

Advancing cancer treatment through innovative therapeutics targeting cell membranes.

Venture round
23 employees
Biotechnology, Health Care
View all alternatives

FAQ About Celcuity

Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy. The company’s lead therapeutic candidate is gedatolisib, a potent, reversible dual inhibitor that selectively targets all Class...
Celcuity was founded in 2012.
Celcuity is headquartered in Minneapolis, United States.
Celcuity operates in Biotechnology, Health Care and Health and Wellness.
Celcuity has approximately 83 employees.
Celcuity has completed 13 funding rounds, raising a total of $335.67M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Celcuity include ENB Therapeutics, TransCode Therapeutics, Inc., AbilityPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celcuity and ENB Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Celcuity, https://bouncewatch.com/company/celcuity, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes